Butterfly Pea (Clitoria ternatea)

Butterfly pea (Clitoria ternatea) is a leguminous plant whose primary bioactive compounds — anthocyanin-based ternatins and cyclotide peptides — drive its antioxidant, neuroprotective, and immunomodulatory effects. These compounds act via free radical scavenging, acetylcholinesterase inhibition, and modulation of inflammatory cytokine pathways.

Origin & History

Clitoria ternatea, also known as butterfly pea, is a perennial herb native to tropical regions like Southeast Asia. It is cultivated for its vibrant blue flowers, used for extracting bioactive compounds such as anthocyanins and cyclotides through methods like ethanolic extraction.

Historical & Cultural Context

Butterfly pea has been used for centuries in Ayurvedic and Southeast Asian traditional medicine as a brain tonic, anti-inflammatory, and diuretic. It is also used as a natural food colorant and eco-friendly insecticide.

Health Benefits

• Acts as an antioxidant, scavenging free radicals (in vitro studies).[2]
• Exhibits anti-proliferative properties in cell lines, suggesting potential anticancer effects (preclinical research).[2][5]
• Demonstrates immunosuppressive properties in preclinical models via cyclotides.[2]
• Possesses insecticidal activity, with cyclotides permeabilizing insect membranes at low concentrations.[2]
• Contains triterpenoids like taraxerol, which show anticancer activity in vitro.[2]

How It Works

Butterfly pea's ternatin anthocyanins scavenge reactive oxygen species and inhibit lipid peroxidation by donating hydrogen atoms to free radicals, protecting cellular membranes. The plant's cyclotide peptides suppress immune activation by inhibiting proliferation of lymphocytes and downregulating pro-inflammatory cytokines including IL-2 and TNF-α. Additionally, root and seed extracts inhibit acetylcholinesterase activity, preserving synaptic acetylcholine levels and supporting cholinergic neurotransmission relevant to cognition and memory.

Scientific Research

No human clinical trials or meta-analyses are available for butterfly pea. The existing research is limited to preclinical studies focused on its antioxidant, anti-proliferative, and insecticidal properties, with no PubMed PMIDs provided for human trials.

Clinical Summary

The majority of evidence for butterfly pea originates from in vitro cell-line studies and rodent models, with very limited human clinical trials. A small Thai crossover study (n=60) found that a single dose of butterfly pea flower extract improved spatial working memory scores compared to placebo, though effect sizes were modest. Preclinical rodent studies demonstrate anxiolytic effects comparable to diazepam at doses of 50–100 mg/kg of aqueous extract, and anti-inflammatory effects have been documented via carrageenan-induced paw edema models. Overall, the evidence base remains preliminary; well-powered, placebo-controlled human RCTs are lacking, limiting definitive efficacy claims.

Nutritional Profile

Butterfly Pea (Clitoria ternatea) flowers and plant parts contain a range of bioactive compounds and nutrients, though comprehensive quantitative nutritional data is primarily derived from leaf, seed, and flower analyses rather than standardized supplement forms. Key components include: 

• ANTHOCYANINS (Primary Bioactives): Flowers contain 1.0–3.0 mg/g dry weight of anthocyanins, predominantly ternatins (polyacylated delphinidin-based anthocyanins: ternatin A1, A2, B1, B2, B3, B4, C1, C2, C3, C4, C5, D1, D2, D3) and delphinidins. These are pH-sensitive pigments responsible for the characteristic blue color. Bioavailability is moderate and influenced by gut microbiota metabolism and food matrix interactions.

• CYCLOTIDES: Cyclic peptides including cliotides (Ct1–Ct32) and kalata-related peptides at approximately 0.1–1.0 mg/g dry plant material. These are resistant to proteolytic degradation, conferring unusual bioavailability for peptide compounds.

• FLAVONOIDS & PHENOLICS: Total flavonoid content in flowers approximately 10–25 mg quercetin equivalents/g dry weight. Includes kaempferol glycosides, quercetin, myricetin, and triterpenoids. Total phenolic content reported at 15–40 mg gallic acid equivalents/g dry weight.

• PROANTHOCYANIDINS & TANNINS: Present in seeds and pods at approximately 2–5% dry weight.

• PROTEIN (Seeds): Seed protein content approximately 17–24% dry weight, containing essential amino acids including lysine (~5.2 g/100g protein), threonine, and methionine (limiting amino acid). Protein digestibility is moderate due to presence of trypsin inhibitors.

• CARBOHYDRATES (Seeds): Total carbohydrate approximately 50–60% dry weight; dietary fiber approximately 6–8% dry weight including both soluble and insoluble fractions.

• LIPIDS (Seeds): Crude fat approximately 2–4% dry weight; fatty acid profile includes palmitic acid (~25%), stearic acid (~5%), oleic acid (~20%), linoleic acid (~40%), and linolenic acid (~5%).

• MINERALS (Leaves/Seeds): Calcium ~120–180 mg/100g dry weight; Iron ~6–12 mg/100g dry weight; Phosphorus ~200–350 mg/100g dry weight; Magnesium ~80–120 mg/100g dry weight; Zinc ~2–4 mg/100g dry weight. Bioavailability of minerals is reduced by presence of phytic acid (0.5–1.2% in seeds).

• VITAMINS: Ascorbic acid (Vitamin C) in fresh leaves approximately 20–40 mg/100g fresh weight; Vitamin A precursors (beta-carotene) approximately 150–300 µg/100g fresh leaves; B vitamins (thiamine, riboflavin, niacin) present in trace amounts in leaves and seeds.

• SAPONINS: Triterpenoid saponins (including clitorins) at approximately 0.5–2.0% dry weight in roots and seeds; may reduce mineral bioavailability and cause GI irritation at high doses.

• STEROLS: Beta-sitosterol, stigmasterol, and campesterol identified in seeds and roots at trace concentrations (~0.1–0.5 mg/g dry weight).

• ALKALOIDS: Trace alkaloids including taraxerol and taraxerone reported in roots.

• BIOAVAILABILITY NOTES: Anthocyanins from flowers show peak plasma appearance within 1–2 hours post-ingestion in general anthocyanin studies; gut microbiome converts anthocyanins to protocatechuic acid and other phenolic metabolites. Cyclotides exhibit unusual oral stability. Anti-nutritional factors (phytates, trypsin inhibitors, saponins) in seeds require soaking/cooking to improve nutrient bioavailability. Most quantitative data derives from South/Southeast Asian cultivars; significant variation exists across growing conditions and plant parts used.

Preparation & Dosage

No clinically studied dosage ranges are available due to the lack of human trials. Traditional uses in food coloring and as an insecticide do not specify biomedical dosing. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea, turmeric, ginger, ashwagandha, ginseng

Safety & Interactions

Butterfly pea is generally regarded as safe when consumed in culinary amounts such as herbal teas, with no serious adverse events reported in short-term human use. Its cyclotides exhibit immunosuppressive properties in preclinical models, raising theoretical concern about additive effects when combined with immunosuppressant drugs such as cyclosporine or corticosteroids. Due to observed uterotonic activity in animal studies, butterfly pea is contraindicated during pregnancy. Individuals taking anticholinergic or cholinergic medications should exercise caution given the plant's acetylcholinesterase inhibitory activity.